July 18, 2024

Freudenberg Medical unveil PharmaFocus Premium and HelixMark Tubing


Freudenberg Medical, a global contract manufacturer for medical device components and biopharma tubing recently unveiled their premium silicone tubing, hose, and assemblies at India’s major pharma expo- CPhi & PMEC India 2021- at Booth 15.D25 held on 24th-26th November.

With this participation, Freudenberg Medical formally steps into India with its range of high-quality fluid handling merchandise. Freudenberg has been manufacturing high purity tubing since 1989 from two dedicated operations in the US and Europe.

As per the firm’s announcement, PharmaFocus Premium silicone tubing was designed to meet the demanding necessities of single-use pharmaceutical and bioprocessing applications and has been extractable tested for BPOG and USP 665 protocols including a full validation package. The PharmaFocus® product line includes standard, braid reinforced, and peristaltic pump tubing.

As per the firm’s announcement, the HelixMark silicone tubing is available off-the-shelf and ready to ship in a wide array of product types and sizes including double-braided, color stripe, peristaltic pump, and opaque tubing as well as stoppers and clamp gaskets. HelixMark also offers a choice of silicone raw material from the major suppliers – Dupont Liveo, Wacker, Momentive, or Nusil

Freudenberg Medical is primarily designing and manufacturing out the HelixMark and PharmaFocus Premium brands of silicone tubing for biopharmaceutical fluid processing.  Custom tubing is also available for oxygen concentrators, ventilators, catheters, and other medical devices.

Statement from David Schwass, Director of Marketing & Distribution, Biopharma at Freudenberg Medical

As per the statement from David Schwass, Director of Marketing & Distribution, Biopharma at Freudenberg Medical stated “Freudenberg Medical’s foray into India is a decisive step in our commitment to India and to provide the best solutions to support the growing needs of the India pharmaceutical market.”

David also added: “Since inception Freudenberg Medical has been at the forefront of pioneering new technologies and processes in healthcare manufacturing. Anticipating our customer needs is the cornerstone of Freudenberg Medical’s success and a reinforcement of our commitment to continuously innovate and enhance value for our customers.”

David also explained, “Our identical manufacturing facilities ensure high-quality products in a cleanroom environment and a secure supply chain for customers. This is a reflection of Freudenberg’s commitment to providing the best and the safest tubing solutions. A dedicated sales and service team in India assures timely order processing and delivery.”

Statement from Falgun Jani, Head of Sales, Freudenberg Medical India

Falgun Jani, Head of Sales, Freudenberg Medical India commented on the firm’s maiden participation at India’s major pharma expo, CPhi stating “Freudenberg Medical’s participation at CPhi is a significant step towards establishing the brand and its range of products among the pharma community and to be the preferred partner for all tubing solutions. Our mission is to always put our customers first and offering local support in India is proof of our commitment to our growing customer base in the region.”

According to a research report by Report Linker, the biopharmaceutical tubing market is anticipated to touch out a base of $6,013.27 million by 2028 from $3,442.82 million in 2021 registering an annual CAGR growth of 8.3%. An aging population and rising demand for minimally invasive procedures are contributing to this growth.

Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal and silicone. In 2020, the silicone segment held the largest share of the market. Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others.

As per the firm’s report, the pharmaceutical arena held the largest market share in 2020, and it is further anticipated to be the major shareholder in the market by 2028.

The fluid transfer is an essential part of pharmaceutical manufacturing processes, comprising of the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) like that of the vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment.

Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industry demands ultra-pure and corrosion-resistant systems for liquid transfer that withstand the harsh environment of chemicals, which is bolstering the market growth of this segment.

Press Release received on Mail.



Bonyan for Investment assigns Savills Egypt to manage its mixed-use commercial space Majarrah
Majarrah partners with Savills Egypt
Mohamed Khattab, Executive Vice President of b_labs and Digital Commerce at B.TECH, and Karim Zein, CEO of Coldwell Banker Egypt during the signing ceremony
B.TECH unveils partnership with Coldwell Banker Egypt
This collaboration between the authority and Roche encompasses two major projects.
The Egyptian Drug Authority partners with Roche
  • logo banner warba
  • Mutual Trust Bank Plc
  • Ahli United Bank


The business landscape is going through continuous change, which means that there are constantly new challenges arising in HR. This blog entails on few of the major challenges arising in 2024
Representational Image
ACCA announces the addition of new Emirati members to its Members’ Advisory Committee with a government-led goal of achieving a 10% increase in Emiratisation of the skilled workforce by 2026
CyberKnight announces VAD partnership with Forescout for META. CyberKnight to offer complete asset intelligence and control across IT, OT, and IoT to Forescout.